Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Clariant AG's accounts receivables for the quarter that ended in Dec. 2025 was CHF614 Mil.
Accounts receivable can be measured by Days Sales Outstanding.
Clariant AG's Days Sales Outstanding for the quarter that ended in Dec. 2025 was 57.94.
In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Clariant AG's Net-Net Working Capital per share for the quarter that ended in Dec. 2025 was CHF-7.23.
Clariant AG Accounts Receivable Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Clariant AG's Days Sales Outstanding for the quarter that ended in Dec. 2025 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.
If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.
Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.
Clariant AG Accounts Receivable Related Terms
Clariant AG Accounts Receivable Historical Data
* Premium members only.
The historical data trend for Clariant AG's Accounts Receivable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Accounts Receivable of CHF614 Mil mean?
Clariant AG (XSWX:CLN) has a Accounts Receivable of CHF614 Mil as of Dec. 2025. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Clariant AG and its competitors.
Is Clariant AG's Accounts Receivable too high?
Clariant AG's current Accounts Receivable is CHF614 Mil. Overall, Clariant AG has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Clariant AG's Accounts Receivable compare to LIN and SHW?
Clariant AG's Accounts Receivable of CHF614 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for a Chemicals company?
A good Accounts Receivable depends on the Chemicals industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Clariant AG and its competitors. Clariant AG's current Accounts Receivable is CHF614 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clariant AG stock overvalued right now?
Based on GuruFocus' analysis, Clariant AG (XSWX:CLN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF9.88, compared to a current price of CHF7.43 — trading 24.8% below its estimated fair value. The current Accounts Receivable is CHF614 Mil. Clariant AG's overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For Clariant AG (XSWX:CLN), the current Accounts Receivable is CHF614 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clariant AG (XSWX:CLN) Overvalued in 2026?
Based on GuruFocus' analysis, Clariant AG stock appears to be undervalued.
The current stock price of CHF7.43 is trading 24.8% below its estimated GF Value™ of CHF9.88.
GuruFocus considers Clariant AG to be Modestly Undervalued.
Key valuation signals for XSWX:CLN:
Accounts Receivable: CHF614 Mil
GF Value™: CHF9.88 vs. price of CHF7.43 (24.8% below fair value)
No single metric tells the full story. See the XSWX:CLN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clariant AG is a Switzerland-based specialty chemicals company with world-wide operations. It develops, manufactures, distributes, and sells a broad range of specialty chemicals, which play a key role in its customers' manufacturing and treatment processes or add value to their end products. The company reports in three business areas: care chemicals, absorbents and additives and catalysts. Care chemicals mainly targets consumer end markets such as personal care and homecare, but it also has an industrial component. Absorbents and additives encompass Clariant's coatings and adhesives, absorbents, and plastics segments. Catalysts manufacturers process catalysts, mainly for petrochemical and syngas plants.
61GF Score
Get the complete analysis for XSWX:CLN
Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:CLN has been successfully added to your 
